Cognitive Impairment in Chronic Kidney Disease Systems

Chronic kidney disease (CKD) is increasingly recognised not only as a renal disorder but also as a systemic condition with profound effects on brain function. Patients with declining kidney function frequently exhibit deficits across multiple cognitive domains, including attention, executive function, processing speed and memory. The underlying mechanisms are multifactorial: uraemic toxins accumulate and directly impair neuronal viability; chronic inflammation, oxidative stress and endothelial dysfunction destabilise the blood–brain barrier; and accelerated small vessel disease leads to white matter lesions and cortical atrophy. Vascular risk factors such as hypertension, diabetes and dyslipidaemia, which are common in CKD, further compound cerebral hypoperfusion and microangiopathy. Neuroimaging studies reveal structural and functional alterations in frontal and parietal networks, while neuropsychological assessments demonstrate both global cognitive decline and domain-specific impairments. These changes have practical implications for treatment adherence, quality of life and long-term morbidity, underscoring the need for integrated renal–neurological management and the identification of modifiable pathways to preserve cognitive health.

Research from Nature Portfolio

Recent animal model studies have begun to delineate the molecular cascades by which renal impairment drives neurological damage. In a reproducible murine model of CKD induced by dietary adenine, investigators observed widespread loss of acetylcholinesterase activity, reduced dendritic complexity and spine density in hippocampal and cortical regions, together with markers of oxidative stress, mitochondrial dysfunction and neuroinflammation. Blood–brain barrier permeability was increased, facilitating entry of circulating toxins. These findings provide a mechanistic framework linking renal failure to synaptic loss and cognitive decline, and identify potential targets—such as antioxidant pathways and inflammatory mediators—for therapeutic intervention.

Cognitive Impairment in Chronic Kidney Disease Systems publication trend

The graph below shows the total number of articles in cognitive impairment in chronic kidney disease systems across all publications each year (not limited to Nature Index journals).

Technical terms

Estimated glomerular filtration rate (eGFR): A calculated index of renal clearance based on serum creatinine and/or cystatin C, used to stage kidney dysfunction.

Albuminuria: Elevated levels of albumin in the urine, indicating glomerular injury and systemic endothelial dysfunction.

Uraemic toxins: Nitrogenous waste products retained in the circulation due to impaired renal excretion, which can exert direct neurotoxic and inflammatory effects.

Blood–brain barrier disruption: A breakdown of the endothelial tight junctions protecting the central nervous system, allowing infiltration of harmful substances.

White matter lesions: Hyperintense regions on magnetic resonance imaging representing demyelination or axonal loss in the brain’s subcortical fibres.

Neuroinflammation: Activation of microglia and astrocytes, leading to release of cytokines and chemokines that contribute to neuronal injury.

References

1. The association between kidney function, cognitive function, and structural brain abnormalities in community-dwelling individuals aged 50+ is mediated by age and biomarkers of cardiovascular disease. Cardiovascular Research (2023).
2. Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank. Alzheimer's Research & Therapy (2023).
3. Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study. American Journal of Kidney Diseases (2024).
4. Neurological sequel of chronic kidney disease: From diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain. Scientific Reports (2019).